New Treatment for IDH mt Gliomas
Jul 20, 2023•18 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Kathryn Nevel talks with Dr. Ingo Mellinghoff about how vorasidenib improved progression-free survival in patients with Isocitrate dehydrogenase (IDH)–mutant grade 2 gliomas.
Read the related article in The New England Journal of Medicine.
Visit NPUb.org/Podcast for associated article links.
For the best experience, listen in Metacast app for iOS or Android